寿惠通便胶囊治疗慢传输型便秘的血清药物化学、16S rDNA测序与代谢组学研究
本研究以地芬诺酯诱导的慢传输型便秘(STC)大鼠模型为对象,结合血清药物化学、16S rDNA测序、脂质组学、质谱成像与分子方法,揭示寿惠通便胶囊(SHTB)治疗STC的物质基础与机制。结果显示SHTB可修复肠道屏障损伤、减轻全身炎症、增加肠道动力,并调节肠道菌群与脂质代谢。
要点
- SHTB可修复STC大鼠肠道屏障损伤、减轻炎症并增加肠道动力。
- SHTB恢复Alloprevotella、Coprococcus、Marvinbryantia等菌群异常。
- SHTB通过减少脂质蓄积和恢复肠道菌群稳态治疗STC。
核心结论
- SHTB治疗STC的关键机制是减少脂质蓄积并恢复肠道微生物稳态。
研究设计与样本
- 采用地芬诺酯诱导的STC大鼠模型,先以LC-MS进行SHTB质量控制获取物质基础,再结合微生物组学、脂质组学、质谱成像和分子方法阐明其调控网络。
主要发现
- SHTB可修复STC大鼠肠道屏障损伤、减少全身炎症并增加肠道动力。
- 16S rDNA测序显示SHTB逆转Alloprevotella、Coprococcus、Marvinbryantia等与STC症状相关的菌群异常。
- 微生物功能预测提示SHTB给药后脂质代谢改善。
- 与STC疾病及SHTB疗效密切相关的差异脂质包括脂肪酸、溶血磷脂酰胆碱、磷脂酰胆碱、鞘磷脂甘油三酯和神经酰胺。
- SHTB显著逆转结肠样本中关键靶酶异常表达,包括CTP-磷酸胆碱胞苷酰转移酶、CTP-磷酸乙醇胺胞苷酰转移酶、磷脂酸磷酸酶、酸性鞘磷脂酶等。
临床怎么用
- 在STC大鼠模型中,SHTB通过调节肠道菌群与脂质代谢发挥治疗作用,提示其临床用于STC的可能机制方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Slow transit constipation (STC) is highly prevalent and has rising incidence. Shouhui Tongbian capsule (SHTB) is a traditional Chinese Medicine formula with extensive and highly efficacious usage in STC treatment, however, its mechanism of action, especially the regulation of microbiome and lipid metabolites, remains unclear. METHODS: After quality control of SHTB using LC‒MS to obtain its material basis, we tried to elucidate the cohesive modulatory network of SHTB against STC using hyphenated methods from microbiomics, lipidomics, mass spectrometry imaging (MSI) and molecular methods. RESULTS: SHTB could repair intestinal barrier damage, reduce systemic inflammation and increase intestinal motility in a diphenoxylate-induced STC rat model. Based on 16S rDNA sequencing results, SHTB rehabilitated the abnormal changes in Alloprevotella, Coprococcus, Marvinbryantia, etc., which were associated with STC symptoms. Meanwhile, microbial functional prediction showed that lipid metabolism was improved with SHTB administration. The differential lipids, including fatty acids, lysophosphatidylcholine, phosphatidylcholine, sphingomyelin triglyceride and ceramide, that are closely related to STC disease and SHTB efficacy. Furthermore, SHTB significantly reversed the abnormal expression of these key target enzymes in colon samples, including CTP-phosphocholine cytidylyltransferase, CTP-phosphoethanolamine cytidylyltransferase, phosphatidic acid phosphatase, acid sphingomyelinase etc. CONCLUSIONS: Combined analysis demonstrated that SHTB reducing lipid accumulation and recovery of intestinal microbial homeostasis was the critical mechanism by which SHTB treats STC.
引用
- Yang J, Xiao H, Yao J, et al. Integrated serum pharmacochemistry, 16S rDNA sequencing, and metabolomics to reveal the material basis and mechanism of Shouhui Tongbian capsule against diphenoxylate-induced slow transit constipation in rats. Chin Med. 2024. PMID: 39394615. doi:10.1186/s13020-024-01015-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。